1-14 of 14
Yasmin Karimi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes following disease progression after epcoritamab or glofitamab in the real-world outcomes of bispecific T-cell engagers (REALBiTE) multi-center, retrospective cohort study

Free
Taylor Brooks, Agrima Mian, Adrienne Nedved, Yucai Wang, Natalie Grover, XI Yang, Yasmin Karimi, Tenley Schwarz, Matthew Schwede, Marshall McKenna, Yun Kyoung Tiger, Nayef Abdel-Razeq, Muhamad Alhaj Moustafa, Catherine Reinert, Ajay Major, Daniel Trotier, Priyanka Pophali, Kelsey Baron, Boyu Hu, Sally Jones, Aditi Saha, Nikita Dave, Daniel Landsburg, Megan Sears-Smith, Nilanjan Ghosh, Kiarash Salafian, Emily Ayers, Suchitra Sundaram, Joshua Brody, Alyssa Gibson, Justin Kline, Javier Munoz, Rodolfo Garza Morales, Eiraj Khan, Cyrus Khan, Brenda Castillo, Stephen Smith, Fadzai Chinyengetere, Sandeep Dave, Alex Niu, Francisco Hernandez-Ilizaliturri, Paolo Caimi, Brian Hill
Journal: Blood
Blood (2025) 146 (Supplement 1): 402.
https://doi.org/10.1182/blood-2025-402
Published: 2025
Journal Articles

Risk factors for cytokine release syndrome and neurotoxicity in patients receiving epcoritamab or glofitamab for large B cell lymphoma: A multi-center, retrospective, real world analysis.

Free
XI Yang, Yasmin Karimi, Xiaoying Chen, Adrienne Nedved, Yucai Wang, Natalie Grover, Tenley Schwarz, Matthew Schwede, Marshall McKenna, Yun Kyoung Tiger, Nayef Abdel-Razeq, Muhamad Alhaj Moustafa, Catherine Reinert, Ajay Major, Daniel Trotier, Priyanka Pophali, Kelsey Baron, Boyu Hu, Sally Jones, Aditi Saha, Nikita Dave, Daniel Landsburg, Megan Sears-Smith, Nilanjan Ghosh, Kiarash Salafian, Emily Ayers, Suchitra Sundaram, Joshua Brody, Justin Kline, Alyssa Gibson, Javier Munoz, Raja Prince-Eladnani, Rodolfo Garza Morales, Cyrus Khan, Brenda Castillo, Stephen Smith, Fadzai Chinyengetere, Sandeep Dave, Alex Niu, Francisco Hernandez-Ilizaliturri, Paolo Caimi, Brian Hill, Taylor Brooks
Journal: Blood
Blood (2025) 146 (Supplement 1): 401.
https://doi.org/10.1182/blood-2025-401
Published: 2025
Journal Articles

Nivolumab with doxorubicin, vinblastine, and dacarbazine (NAVD) in older adults with classic Hodgkin lymphoma: Do S1826 results hold up in the real world?

Free
Pallawi Torka, Allison Bock, Elena Nazarenko, Yizhe Xu, John Vaughn, Swetha Thiruvengadam, Ajay Major, Kanithra Sekaran, Daniel Reef, Calvin Lee, Gordon Smilnak, Efrat Luttwak, Vrutti Patel, Harsh Shah, Andrew Ip, Grace Baek, Ritwick Mynam, Dahlia Sano, Drew Gerber, Ayo Falade, Marisa Palmeri, Rudy Mrad, Madiha Iqbal, John Sharp, Timothy Voorhees, Praveen Ramakrishnan Geethakumari, Joanna Rhodes, Urshila Durani, Hua-Jay Cherng, Yasmin Karimi, Priyanka Pophali, Mengyang Di, Tatyana Feldman, Jakub Svoboda, Krithika Shanmugasundaram, Alex Niu, Natalie Grover, Reem Karmali, Alex Herrera, Catherine Diefenbach, Narendranath Epperla
Journal: Blood
Blood (2025) 146 (Supplement 1): 3622.
https://doi.org/10.1182/blood-2025-3622
Published: 2025
Journal Articles

Outcomes of second line platinum salvage and autologous stem cell transplant compared to CD19 CAR-T in patients with Relapsed/Refractory primary mediastinal B-cell lymphoma: A multi-center, retrospective analysis

Free
XI Yang, Henry Dumke, Joseph Schroers-Martin, Yazeed Sawalha, Sree Lanka, Izel Okcu, Grzegorz Nowakowski, Peter Doukas, Reem Karmali, Meryl Colton, Michael Spinner, Vincenzo Pizzuti, Manali Kamdar, Olutobi Adewale, Yun Kyoung Tiger, Kelsey Baron, Allison Bock, Marcus Geer, Yasmin Karimi
Journal: Blood
Blood (2025) 146 (Supplement 1): 783.
https://doi.org/10.1182/blood-2025-783
Published: 2025
Journal Articles

Twelve month landmark analysis of outcomes of relapsed or refractory large B-cell lymphoma patients achieving prolonged remission with glofitamab or epcoritamab in the real-world outcomes of bispecific T-cell engagers (REALBiTE) multi-center, retrospective cohort study

Free
Taylor Brooks, Adrienne Nedved, Yucai Wang, Natalie Grover, XI Yang, Yasmin Karimi, Tenley Schwarz, Matthew Schwede, Marshall McKenna, Yun Kyoung Tiger, Nayef Abdel-Razeq, Muhamad Alhaj Moustafa, Catherine Reinert, Ajay Major, Daniel Trotier, Priyanka Pophali, Kelsey Baron, Boyu Hu, Sally Jones, Aditi Saha, Nikita Dave, Daniel Landsburg, Megan Sears-Smith, Nilanjan Ghosh, Kiarash Salafian, Emily Ayers, Suchitra Sundaram, Joshua Brody, Alyssa Gibson, Justin Kline, Javier Munoz, Rodolfo Garza Morales, Eiraj Khan, Cyrus Khan, Brenda Castillo, Stephen Smith, Fadzai Chinyengetere, Sandeep Dave, Alex Niu, Francisco Hernandez-Ilizaliturri, Paolo Caimi, Brian Hill
Journal: Blood
Blood (2025) 146 (Supplement 1): 4499.
https://doi.org/10.1182/blood-2025-4499
Published: 2025
Journal Articles

Genomic and immune determinants of response to CD3 x CD20 bispecific antibodies in aggressive B-cell lymphoma

Free
XI Yang, Weiwei Zhang, Anamarija Perry, Pinyu Hou, Winston Lee, James Godfrey, Yasmin Karimi, Joo Song
Journal: Blood
Blood (2025) 146 (Supplement 1): 3542.
https://doi.org/10.1182/blood-2025-3542
Published: 2025
Journal Articles

A real-world analysis of safety and outcomes with first line nivolumab in combination with doxorubicin, vinblastine, and dacarbazine (NAVD) in patients with classic Hodgkin lymphoma (cHL) – a multicenter cohort study

Free
Allison Bock, Efrat Luttwak, Elena Nazarenko, Yizhe Xu, Swetha Thiruvengadam, Dahlia Sano, Kanithra Sekaran, John Vaughn, Daniel Reef, John Sharp, Ajay Major, Vrutti Patel, Nicole Araujo, Ritwick Mynam, Gordon Smilnak, Marisa Palmeri, Anuja Abhyankar, Drew Gerber, Ayo Falade, Praveen Ramakrishnan Geethakumari, Madiha Iqbal, Grace Baek, Mengyang Di, Boyu Hu, Urshila Durani, Hua-Jay Cherng, Alex Niu, Joanna Rhodes, Krithika Shanmugasundaram, Priyanka Pophali, Tatyana Feldman, Jakub Svoboda, Timothy Voorhees, Natalie Grover, Catherine Diefenbach, Reem Karmali, Yasmin Karimi, Alex Herrera, Pallawi Torka, Narendranath Epperla
Journal: Blood
Blood (2025) 146 (Supplement 1): 1841.
https://doi.org/10.1182/blood-2025-1841
Published: 2025
Journal Articles

Sustained remissions beyond 4 years with epcoritamab monotherapy: Long term follow-up results from the pivotal EPCORE NHL-1 trial in patients with relapsed or refractory large B-cell lymphoma

Free
Yasmin Karimi, Chan Cheah, Julie Vose, Michael Roost Clausen, David Cunningham, Umar Farooq, Tatyana Feldman, Herve Ghesquieres, Wojciech Jurczak, Kim Linton, Tycel Phillips, Won Seog Kim, Pegah Jafarinasabian, Barbara D'Angelo Månsson, Milan Geybels, Christian Eskelund, Martin Hutchings, Catherine Thieblemont
Journal: Blood
Blood (2025) 146 (Supplement 1): 5513.
https://doi.org/10.1182/blood-2025-5513
Published: 2025
Journal Articles

Evaluation of real-world outcomes with zanubrutinib in patients with marginal zone lymphoma: Results from multicenter cohort study

Free
Narendranath Epperla, Geoffrey Shouse, Jess Hatfield, Kanithra Sekaran, Yun Choi, Aishwarya Sannareddy, Bryce Bowler, Zain El-amir, Ly Do, Matthew Savas, Taylor Kujawa, Priyanka Pophali, Yasmin Karimi, Mengyang Di, Praveen Ramakrishnan Geethakumari, Yazeed Sawalha, Reem Karmali, Natalie Grover, Adam Olszewski
Journal: Blood
Blood (2025) 146 (Supplement 1): 4534.
https://doi.org/10.1182/blood-2025-4534
Published: 2025
Journal Articles

Evaluation of outcomes and toxicities of loncastuximab tesirine (Lonca) in relapse/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL): Real-world data analysis (RWDA) from 10 US academic centers

Free
Alex Niu, Alan Hutson, Joseph Parker, Muhamad Alhaj Moustafa, Sherwin Kelekar, Yasmin Karimi, Arshed Al-Obeidi, Natalie Grover, Allison Bock, Kelsey Baron, Narendranath Epperla, Suheil Albert Atallah-Yunes, Yucai Wang, Talal Hilal, Catherine Reinert, Ajay Major, Megan Sears-Smith, Nilanjan Ghosh, Meghana Subramanian, Yun Kyoung Tiger, Matthew Cortese, Francisco Hernandez-Ilizaliturri
Journal: Blood
Blood (2025) 146 (Supplement 1): 4514.
https://doi.org/10.1182/blood-2025-4514
Published: 2025
Journal Articles

Epcoritamab + R-mini-CHOP results in 2-year remissions and high MRD negativity rates in elderly patients with newly diagnosed DLBCL: Results from the EPCORE NHL-2 trial

Free
Chan Cheah, Juraj Ďuraš, David Belada, Justin Darrah, Yasmin Karimi, Franck Morschhauser, Gerardo Musuraca, Mats Hellstrom, Katerina Kopeckova, Lori Leslie, Anna Sureda Balarí, Catherine Thieblemont, Umberto Vitolo, Kojo Osei-Bonsu, Yi Hao, Monica Wielgos-Bonvallet, Mina Khoshdeli, Aidan Reilly, Malene Risum, Joost Vermaat, Joshua Brody
Journal: Blood
Blood (2025) 146 (Supplement 1): 64.
https://doi.org/10.1182/blood-2025-64
Published: 2025
Journal Articles

High-Grade B-Cell Lymphoma, Not Otherwise Specified (HGBL, NOS): Central Nervous System (CNS) Involvement, Prophylaxis, and Recurrence Risk in a Multi-Institutional Series

Free
Narendranath Epperla, Adam Zayac, Daniel J. Landsburg, Mitchell Hughes, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Girton, Marie Hu, Amy Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E. Chang, Adam Stepanovic, Habibe Kurt, Jose Sandoval-Sus, M. Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L Xu, Pallawi Torka, Suchitra Sundaram, Stephen D Smith, Kikkeri N Naresh, Yasmin Karimi, David A. Bond, Umar Farooq, Mahak Saad, Andrew Matthew Evens, Karan Pandya, Seema G Naik, Manali Kamdar, Bradley M. Haverkos, Reem Karmali, Timothy S Oh, Julie M. Vose, Heather Nutsch, Paul Rubinstein, Amina Chaudhry, Adam J. Olszewski
Journal: Blood
Blood (2022) 140 (Supplement 1): 3839–3841.
https://doi.org/10.1182/blood-2022-157105
Published: 2022
Journal Articles

Phase 2 Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Plamotamab Combined with Tafasitamab (Tafa) + Lenalidomide (Len) Vs Tafa+Len in Relapsed or Refractory DLBCL

Free
Krish Patel, Youngil Koh, Sabarish Ayyappan, Yasmin Karimi, Izidore S. Lossos, Akil Merchant, Phuong Lee, Jianhua Jin, Raphael Clynes, Jitendra Kanodia, Michael T. Chiarella, Steve Kye, Jean-Marie Michot
Journal: Blood
Blood (2022) 140 (Supplement 1): 12066–12067.
https://doi.org/10.1182/blood-2022-158042
Published: 2022
Journal Articles

High-Grade B-Cell Lymphoma, Not Otherwise Specified (HGBL, NOS): Characteristics, Treatment, and Outcomes from 17 Academic US Centers

Free
Adam Zayac, Daniel J Landsburg, Mitchell Hughes, Emily C. Ayers, Mark Girton, Marie Hu, Amy Beckman, Shaoying Li, L. Jeffrey Medeiros, Habibe Kurt, Jose Sandoval-Sus, M. Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L. Xu, Pallawi Torka, Suchitra Sundaram, Stephen D. Smith, Kikkeri N Naresh, Yasmin Karimi, Narendranath Epperla, David A. Bond, Andrew M. Evens, Karan Pandya, Seema G Naik, Manali Kamdar, Brad Haverkos, Reem Karmali, Timothy Seijung Oh, Julie M. Vose, Heather Nutsch, Paul Rubinstein, Amina Chaudhry, Adam J. Olszewski
Journal: Blood
Blood (2021) 138 (Supplement 1): 455.
https://doi.org/10.1182/blood-2021-144308
Published: 2021